CORRECTION article

Front. Oncol., 18 September 2023

Sec. Gastrointestinal Cancers: Colorectal Cancer

Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1283480

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy

  • 1. The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

  • 2. The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

  • 3. GE Healthcare Pharmaceutical Diagnostics, Guangzhou, China

Text Correction

In the published article, there was an error. A correction was made to Author contributions. In the published original article this section previously stated:

“SY: Formal analysis, Investigation, Writing - original draft. YH: Investigation KXN: Investigation YTL: Methodology, Software. XCT: Conceptualization, Supervision, writing – review and editing. XMP participated in data collection, data analyses, software, and interpretation. All authors contributed to the article and approved the submitted version”.

The corrected version appears below:

“SY, YH and XP are co-authors. SY: Formal analysis, Investigation, Writing - original draft. YH: Investigation KN: Investigation YL: Methodology, Software. XCM: Conceptualization, Supervision, writing – review and editing. XP participated in data collection, data analyses, software, and interpretation. All authors contributed to the article and approved the submitted version”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

radiomics, computed tomography, progression-free survival, colorectal liver metastases, chemotherapy

Citation

Ye S, Han Y, Pan X, Niu K, Liao Y and Meng X (2023) Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy. Front. Oncol. 13:1283480. doi: 10.3389/fonc.2023.1283480

Received

26 August 2023

Accepted

05 September 2023

Published

18 September 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2023

Updates

Copyright

*Correspondence: XiaoChun Meng,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics